1. Bhowmik, Khokon Kanti, Barek, Md Abdul, Aziz, Md Abdul, Islam, Mohammad Safiqul. . Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case-Control Studies. In Technology in cancer research & treatment, 21, 15330338221123109. doi:10.1177/15330338221123109. https://pubmed.ncbi.nlm.nih.gov/36254562/
2. Xu, Teng, Yang, Yuemei, Chen, Zhihong, Wu, Yunong, Song, Xiaomeng. 2023. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling. In Journal of experimental & clinical cancer research : CR, 42, 190. doi:10.1186/s13046-023-02775-1. https://pubmed.ncbi.nlm.nih.gov/37525222/
3. Jia, Lin, Shi, Yundong, Wen, Yi, Feng, Jing, Chen, Ceshi. 2018. The roles of TNFAIP2 in cancers and infectious diseases. In Journal of cellular and molecular medicine, 22, 5188-5195. doi:10.1111/jcmm.13822. https://pubmed.ncbi.nlm.nih.gov/30145807/
4. Guo, Fang, Xu, Qian, Lv, Zhi, Zheng, Zhen-Dong, Yuan, Yuan. 2020. Correlation Between TNFAIP2 Gene Polymorphism and Prediction/Prognosis for Gastric Cancer and Its Effect on TNFAIP2 Protein Expression. In Frontiers in oncology, 10, 1127. doi:10.3389/fonc.2020.01127. https://pubmed.ncbi.nlm.nih.gov/32793480/
5. Lin, Mei-Si, Zhong, Hui-Yun, Yim, Rita Lok-Hay, Gao, Fei, Zhang, Min-Yue. 2022. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. In BMC cancer, 22, 1068. doi:10.1186/s12885-022-10155-9. https://pubmed.ncbi.nlm.nih.gov/36243694/
智鼠故事 
